Purchases and Sales Made in Q1 2023 in Monte Rosa Therapeutics, Inc. (GLUE)
This table provides information about the institutional ownership of Monte Rosa Therapeutics, Inc. (GLUE) during Q1 2023. The information is specifically focused on institutions that hold shares of Monte Rosa Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 11, 2023
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-11.7K- 26.68% |
$69.8K - $96.3K
|
32.2K
$160K
|
|
|
May 11, 2023
Q1 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-16.7K- 91.2% |
$99.5K - $137K
|
1.61K
$8.02K
|
|
|
May 12, 2023
Q1 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-29.2K- 36.93% |
$174K - $240K
|
49.9K
$248K
|
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-69.5K- 64.5% |
$413K - $570K
|
38.2K
$190K
|
|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-204K- 20.96% |
$1.21M - $1.68M
|
770K
$3.83M
|
|
|
May 15, 2023
Q1 2023
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-217K- 11.24% |
$1.29M - $1.79M
|
1.72M
$8.53M
|
|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-276K- 70.22% |
$1.64M - $2.27M
|
117K
$582K
|